Characterize the feed
Review protein concentration, aggregates, impurities, and the effects of preceding process steps.
Biopharma · APPLICATION GUIDE
Virus Filtration
Clearly distinguish the roles of virus-removal filters and the pretreatment filters that protect them.
Review selection pointsDiscuss this applicationFIELD APPLICATION & FLOW
See the application in its industrial setting.
Review product locations and fluid paths.
APPLICATION IN CONTEXT
- Purified-protein feed
- Protective prefilter
- Dedicated virus filter
- Product collection
- Process/test record
Connections to review
- 01 → 02 Purified-protein feed → Protective prefilter
- 02 → 03 Protective prefilter → Dedicated virus filter
- 03 → 04 Dedicated virus filter → Product collection
- 03 → 05 Pressure/time record
Distinguish protective prefiltration from dedicated virus removal. Do not apply this protein-process example universally to viral vectors.
A conceptual illustration created to explain equipment and application locations. It is not an actual product photograph, installation photograph or piping/wiring design.
Connection principles and operating/test methods
Protective prefiltration and virus removal
Fluid
Scroll horizontally to see the complete flow.
Prefiltration does not replace the virus-removal membrane. This diagram describes removing viruses as impurities, which is distinct from recovering a viral-vector product.
These conceptual views explain flow direction. Actual piping, wiring and physical flow rates require a separate design.
01 — PROCESS
Where does each step fit?
Define the intended use and conditions to identify the required role of each item.
Compare pretreatment options
Compare virus filter capacity and product losses with and without pretreatment.
Validate the dedicated filter
Review removal performance under the relevant process conditions, process interruptions, and integrity acceptance criteria.
02 — SELECTION
What should be selected and verified?
Viral safety is evaluated through a combination of raw material controls and multiple removal and inactivation steps. Pretreatment aims to reduce aggregate and particle loads to stabilize downstream capacity; it does not automatically imply that pretreatment itself removes viruses.
Scroll horizontally to review all columns.
| Process objective | Step to review | Selection evidence |
|---|---|---|
| Upstream aggregates | Protective pretreatment | Aggregate and particle reduction, and target product adsorption |
| Virus removal | Dedicated virus filters | Model viruses, process conditions, and validation strategy |
| Capacity stabilization | Loading, pressure, and time | Protein concentration, flux decline, and effects of pressure interruptions |
| Batch completion | Recovery and testing | Flushing losses, integrity testing, and record traceability |
These examples start the application review. Pore size or nominal rating alone does not establish suitability or retention; confirm with the actual process fluid and supplier evidence.
03 — OPERATING CHECKS
Use operating data to identify improvements.
Check the scope of performance claims
Do not directly apply results obtained with other products, buffers, or viruses.
Include process interruption conditions
Review the effects of actual scenarios such as stopping and restarting, low pressure, and maximum processing time.
Compare total downstream costs
Even if pretreatment adds cost, it may reduce dedicated filter area or product losses. Make the assessment on the basis of total batch cost.
04 — QUESTIONS
Frequently asked questions
Can an ordinary microfiltration filter be used as a substitute?
It cannot be considered equivalent to a dedicated virus-removal filter. Clearly distinguish their intended purposes and validation data.
How can the benefit of pretreatment be demonstrated?
Compare capacity, aggregates, pressure trends, and product recovery using the same feed and downstream conditions.
05 — APPLICATION REVIEW
Prepare the conditions for a technical discussion.
These details help narrow the configuration and the evidence to review.
- Product platform, concentration, and aggregate levels
- Current virus filtration configuration
- Batch volume, pressure, time, and interruption conditions
- Pretreatment status and capacity data
- Recovery and validation documentation requirements